Assignment of Assignor's Interest

Recorded: 2016-04-20 Pages: 7

Assignor

XIGEN S.A.

Executed: 2013-08-23

Assignee

XIGEN INFLAMMATION LTD.

ARCH. MAKARIOU III, 195 NEOCLEOUS HOUSE, LIMASSOL, 3030, CYPRUS

Covered Property (1)

Use of Cell-Permeable Peptide Inhibitors of the Jnk Signal Transduction Pathway for the Treatment of Chronic or Non-Chronic Inflammatory Eye Diseases

Application: 14/849,374 →

Publication: US 2016/0089413

Related Assignments (1)

Other recorded transfers of the patent in this record — the chain of ownership.